Biotech stories
Research teams could see faster target discovery as OpenAI opens GPT-Rosalind to qualified US customers for biology and drug discovery work.
The Danish quantum software firm is pushing into life sciences now, adding senior hires and partners to sell hybrid tools before the market matures.
A handful of US artificial intelligence megadeals pushed global venture capital investment to USD $330.9 billion in the first quarter, KPMG said.
Pharmaceutical field teams could cut hours of searching to seconds as ACTO's new system routes approved information through compliance checks.
Iran-linked wiper cyber attack cripples Stryker plants, disrupting implant production and locking thousands of staff out of global networks.
Biotech's next leaders will be defined less by scientific breakthroughs and more by diverse teams building resilient clinical infrastructure.
Belfast tech firm SciLeads will create 60 fully remote roles over three years as it scales its life sciences market intelligence platform.
Anthropic rolls out Claude for Healthcare and Life Sciences, adding sector-specific connectors, agent skills and consumer health integrations.
British Columbia inks Karnataka life sciences pact in Bengaluru push to deepen biotech, medtech and digital health trade ties with India.
Canada’s health tech sector is struggling to turn strong research into commercial scale, as panellists split over whether policy or private capital should lead.
The move gives UK life sciences firms a new source of scale-up capital as a funding gap has left many promising businesses short of backing.
The London biotech startup will use new funding to broaden deployments at major drugmakers, including Pfizer, and speed research decisions.
The funding will help expand Vancouver research, manufacturing and clinical trials, with hundreds of jobs and student co-op places expected to follow.
The extra cash will help the deeptech fund back more science-led start-ups outside London at larger pre-seed and seed rounds.
Expleo appoints Alan Gallagher to spearhead its life sciences expansion in Ireland, targeting pharma growth and digital modernisation.
Wilbe launches flexible life sciences lab hub in White City to tackle early-stage startup space crunch and back scientist founders.
CVCA: Canadian venture capital slid in 2025 even as private equity soared to CAD $57.5 billion, fuelled by a handful of mega-deals.
British Business Bank pledges up to GBP £50 million to IQ Capital Fund V, reinforcing a 20-year partnership backing UK deep tech.
A little-known research network, built before the cloud, now underpins Canada's AI, biotech and climate science - but its future is uncertain.
ScotlandIS flags AI, skills, green data centres and cyber basics as critical to Scotland's digital economy amid 2026 uncertainty.
